ID   BCKD_RAT                Reviewed;         412 AA.
AC   Q00972; Q64552;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   24-JUL-2024, entry version 188.
DE   RecName: Full=Branched-chain alpha-ketoacid dehydrogenase kinase {ECO:0000250|UniProtKB:O14874};
DE            Short=BCKDH kinase {ECO:0000250|UniProtKB:O14874};
DE            Short=BCKDHKIN;
DE            Short=BDK {ECO:0000250|UniProtKB:O14874};
DE            EC=2.7.11.1 {ECO:0000305|PubMed:29779826};
DE   AltName: Full=[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial;
DE            EC=2.7.11.4 {ECO:0000269|PubMed:1377677, ECO:0000269|PubMed:7649998};
DE   Flags: Precursor;
GN   Name=Bckdk;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 31-67; 93-100; 254-260 AND
RP   328-343, TISSUE SPECIFICITY, AND CATALYTIC ACTIVITY.
RC   TISSUE=Heart;
RX   PubMed=1377677; DOI=10.1016/s0021-9258(18)42179-5;
RA   Popov K.M., Zhao Y., Shimomura Y., Kuntz M.J., Harris R.A.;
RT   "Branched-chain alpha-ketoacid dehydrogenase kinase. Molecular cloning,
RT   expression, and sequence similarity with histidine protein kinases.";
RL   J. Biol. Chem. 267:13127-13130(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Heart;
RX   PubMed=1496922; DOI=10.1016/0065-2571(92)90022-r;
RA   Harris R.A., Popov K.M., Shimomura Y., Zhao Y., Jaskiewicz J., Nanaumi N.,
RA   Suzuki M.;
RT   "Purification, characterization, regulation and molecular cloning of
RT   mitochondrial protein kinases.";
RL   Adv. Enzyme Regul. 32:267-284(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 31-412, SEQUENCE REVISION TO 110-124 AND 222,
RP   PHOSPHORYLATION AT SER-31, AND CATALYTIC ACTIVITY.
RC   TISSUE=Kidney;
RX   PubMed=7649998; DOI=10.1074/jbc.270.34.19861;
RA   Davie J.R., Wynn R.M., Meng M., Huang Y.-S., Aalund G., Chuang D.T.,
RA   Lau K.S.;
RT   "Expression and characterization of branched-chain alpha-ketoacid
RT   dehydrogenase kinase from the rat. Is it a histidine-protein kinase?";
RL   J. Biol. Chem. 270:19861-19867(1995).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31; SER-356 AND SER-360, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=29779826; DOI=10.1016/j.cmet.2018.04.015;
RA   White P.J., McGarrah R.W., Grimsrud P.A., Tso S.C., Yang W.H.,
RA   Haldeman J.M., Grenier-Larouche T., An J., Lapworth A.L., Astapova I.,
RA   Hannou S.A., George T., Arlotto M., Olson L.B., Lai M., Zhang G.F.,
RA   Ilkayeva O., Herman M.A., Wynn R.M., Chuang D.T., Newgard C.B.;
RT   "The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via
RT   Regulation of ATP-Citrate Lyase.";
RL   Cell Metab. 27:1281-1293.e7(2018).
RN   [6] {ECO:0007744|PDB:1GJV, ECO:0007744|PDB:1GKX, ECO:0007744|PDB:1GKZ}
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 31-412 IN COMPLEX WITH ATP;
RP   MG(2+) AND K(+), SUBUNIT, AND ACTIVITY REGULATION.
RX   PubMed=11562470; DOI=10.1073/pnas.201220098;
RA   Machius M., Chuang J.L., Wynn R.M., Tomchick D.R., Chuang D.T.;
RT   "Structure of rat BCKD kinase: nucleotide-induced domain communication in a
RT   mitochondrial protein kinase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:11218-11223(2001).
CC   -!- FUNCTION: Serine/threonine-protein kinase component of macronutrients
CC       metabolism. Forms a functional kinase and phosphatase pair with PPM1K,
CC       serving as a metabolic regulatory node that coordinates branched-chain
CC       amino acids (BCAAs) with glucose and lipid metabolism via two distinct
CC       phosphoprotein targets: mitochondrial BCKDHA subunit of the branched-
CC       chain alpha-ketoacid dehydrogenase (BCKDH) complex and cytosolic ACLY,
CC       a lipogenic enzyme of Krebs cycle (Probable) (PubMed:1377677,
CC       PubMed:7649998). Phosphorylates and inactivates mitochondrial BCKDH
CC       complex a multisubunit complex consisting of three multimeric
CC       components each involved in different steps of BCAA catabolism: E1
CC       composed of BCKDHA and BCKDHB, E2 core composed of DBT monomers, and E3
CC       composed of DLD monomers. Associates with the E2 component of BCKDH
CC       complex and phosphorylates BCKDHA on Ser-333, leading to conformational
CC       changes that interrupt substrate channeling between E1 and E2 and
CC       inactivates the BCKDH complex (Probable) (PubMed:1377677,
CC       PubMed:7649998). phosphorylates ACLY on Ser-455 in response to changes
CC       in cellular carbohydrate abundance such as occurs during fasting to
CC       feeding metabolic transition. Refeeding stimulates MLXIPL/ChREBP
CC       transcription factor, leading to increased BCKDK to PPM1K expression
CC       ratio, phosphorylation and activation of ACLY that ultimately results
CC       in the generation of malonyl-CoA and oxaloacetate immediate substrates
CC       of de novo lipogenesis and glucogenesis, respectively (Probable).
CC       Recognizes phosphosites having SxxE/D canonical motif (By similarity).
CC       {ECO:0000250|UniProtKB:O14874, ECO:0000269|PubMed:1377677,
CC       ECO:0000269|PubMed:7649998, ECO:0000305|PubMed:29779826}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[3-methyl-2-oxobutanoate dehydrogenase] = ADP +
CC         H(+) + O-phospho-L-seryl-[3-methyl-2-oxobutanoate dehydrogenase];
CC         Xref=Rhea:RHEA:17301, Rhea:RHEA-COMP:13695, Rhea:RHEA-COMP:13696,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.4;
CC         Evidence={ECO:0000269|PubMed:1377677, ECO:0000269|PubMed:7649998,
CC         ECO:0000305|PubMed:29779826};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17302;
CC         Evidence={ECO:0000269|PubMed:7649998, ECO:0000305|PubMed:1377677,
CC         ECO:0000305|PubMed:29779826};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000305|PubMed:29779826};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17990;
CC         Evidence={ECO:0000305|PubMed:29779826};
CC   -!- ACTIVITY REGULATION: The ATP-ase activity is up-regulated by potassium
CC       and rubidium ions but not by sodium ions. Up-regulated in the presence
CC       of apo- or lipoylated-DBT/E2b subunit of the BCKDH complex.
CC       {ECO:0000269|PubMed:11562470}.
CC   -!- SUBUNIT: Homodimer. Homotetramer (PubMed:11562470). Dimerizes through
CC       interaction of two opposing nucleotide-binding domains. Interacts with
CC       E2 component of the branched-chain alpha-ketoacid dehydrogenase (BCKDH)
CC       complex. Competes with BCKDK for binding to the E2 component; this
CC       interaction is modulated by branched-chain alpha-keto acids. At steady
CC       state, BCKDH holoenzyme contains BCKDK and BCKDHA is phosphorylated. In
CC       response to high levels of branched-chain alpha-keto acids, the
CC       inhibitory BCKDK is replaced by activating PPM1K leading to BCKDHA
CC       dephosphorylation and BCAA degradation (By similarity).
CC       {ECO:0000250|UniProtKB:O14874, ECO:0000269|PubMed:11562470}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix. Mitochondrion
CC       {ECO:0000269|PubMed:29779826}. Note=Detected in the cytosolic
CC       compartment of liver cells. {ECO:0000269|PubMed:29779826}.
CC   -!- TISSUE SPECIFICITY: Expressed in heart and liver.
CC       {ECO:0000269|PubMed:1377677}.
CC   -!- PTM: Autophosphorylated. {ECO:0000269|PubMed:7649998}.
CC   -!- SIMILARITY: Belongs to the PDK/BCKDK protein kinase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M93271; AAA40818.1; -; mRNA.
DR   EMBL; U27456; AAB60498.1; -; mRNA.
DR   PIR; A42924; A42924.
DR   RefSeq; NP_062117.2; NM_019244.2.
DR   PDB; 1GJV; X-ray; 2.70 A; A=31-412.
DR   PDB; 1GKX; X-ray; 2.30 A; A=31-412.
DR   PDB; 1GKZ; X-ray; 2.20 A; A=31-412.
DR   PDB; 3TZ0; X-ray; 2.50 A; A=1-412.
DR   PDB; 3TZ2; X-ray; 2.85 A; A=1-412.
DR   PDB; 3TZ4; X-ray; 2.25 A; A=1-412.
DR   PDB; 3TZ5; X-ray; 2.40 A; A=1-412.
DR   PDB; 3VAD; X-ray; 2.60 A; A=1-412.
DR   PDB; 4DZY; X-ray; 2.10 A; A=1-412.
DR   PDB; 4E00; X-ray; 2.15 A; A=1-412.
DR   PDB; 4E01; X-ray; 1.97 A; A=1-412.
DR   PDB; 4E02; X-ray; 2.15 A; A=1-412.
DR   PDB; 4H7Q; X-ray; 2.10 A; A=1-412.
DR   PDB; 4H81; X-ray; 2.05 A; A=1-412.
DR   PDB; 4H85; X-ray; 2.10 A; A=1-412.
DR   PDB; 8EGD; X-ray; 2.05 A; A=31-412.
DR   PDB; 8EGF; X-ray; 1.85 A; A=31-412.
DR   PDB; 8EGQ; X-ray; 1.96 A; A=31-412.
DR   PDB; 8EGU; X-ray; 1.92 A; A=31-412.
DR   PDB; 8F4Q; X-ray; 2.15 A; A=31-412.
DR   PDBsum; 1GJV; -.
DR   PDBsum; 1GKX; -.
DR   PDBsum; 1GKZ; -.
DR   PDBsum; 3TZ0; -.
DR   PDBsum; 3TZ2; -.
DR   PDBsum; 3TZ4; -.
DR   PDBsum; 3TZ5; -.
DR   PDBsum; 3VAD; -.
DR   PDBsum; 4DZY; -.
DR   PDBsum; 4E00; -.
DR   PDBsum; 4E01; -.
DR   PDBsum; 4E02; -.
DR   PDBsum; 4H7Q; -.
DR   PDBsum; 4H81; -.
DR   PDBsum; 4H85; -.
DR   PDBsum; 8EGD; -.
DR   PDBsum; 8EGF; -.
DR   PDBsum; 8EGQ; -.
DR   PDBsum; 8EGU; -.
DR   PDBsum; 8F4Q; -.
DR   AlphaFoldDB; Q00972; -.
DR   SMR; Q00972; -.
DR   BioGRID; 248235; 1.
DR   IntAct; Q00972; 4.
DR   STRING; 10116.ENSRNOP00000069014; -.
DR   iPTMnet; Q00972; -.
DR   PhosphoSitePlus; Q00972; -.
DR   PaxDb; 10116-ENSRNOP00000026466; -.
DR   Ensembl; ENSRNOT00000078578.2; ENSRNOP00000069014.1; ENSRNOG00000019485.7.
DR   Ensembl; ENSRNOT00055051927; ENSRNOP00055042864; ENSRNOG00055029958.
DR   Ensembl; ENSRNOT00065025493; ENSRNOP00065020009; ENSRNOG00065015374.
DR   GeneID; 29603; -.
DR   KEGG; rno:29603; -.
DR   UCSC; RGD:2198; rat.
DR   AGR; RGD:2198; -.
DR   CTD; 10295; -.
DR   RGD; 2198; Bckdk.
DR   eggNOG; KOG0787; Eukaryota.
DR   GeneTree; ENSGT00940000159512; -.
DR   InParanoid; Q00972; -.
DR   OMA; WSYPPSA; -.
DR   OrthoDB; 3058550at2759; -.
DR   PhylomeDB; Q00972; -.
DR   TreeFam; TF331303; -.
DR   BRENDA; 2.7.11.4; 5301.
DR   Reactome; R-RNO-70895; Branched-chain amino acid catabolism.
DR   SABIO-RK; Q00972; -.
DR   EvolutionaryTrace; Q00972; -.
DR   PRO; PR:Q00972; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000019485; Expressed in pancreas and 19 other cell types or tissues.
DR   ExpressionAtlas; Q00972; baseline and differential.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0045252; C:oxoglutarate dehydrogenase complex; IDA:HGNC-UCL.
DR   GO; GO:0047323; F:[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity; IMP:RGD.
DR   GO; GO:0005524; F:ATP binding; IDA:HGNC-UCL.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:HGNC-UCL.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; ISO:RGD.
DR   GO; GO:0004740; F:pyruvate dehydrogenase (acetyl-transferring) kinase activity; IBA:GO_Central.
DR   GO; GO:0009083; P:branched-chain amino acid catabolic process; IDA:HGNC-UCL.
DR   GO; GO:0006550; P:isoleucine catabolic process; IMP:RGD.
DR   GO; GO:0006552; P:L-leucine catabolic process; IMP:RGD.
DR   GO; GO:0008610; P:lipid biosynthetic process; ISO:RGD.
DR   GO; GO:0016310; P:phosphorylation; IDA:HGNC-UCL.
DR   GO; GO:0010906; P:regulation of glucose metabolic process; IBA:GO_Central.
DR   GO; GO:0007283; P:spermatogenesis; IMP:RGD.
DR   GO; GO:0006574; P:valine catabolic process; IMP:RGD.
DR   CDD; cd16929; HATPase_PDK-like; 1.
DR   Gene3D; 1.20.140.20; Alpha-ketoacid/pyruvate dehydrogenase kinase, N-terminal domain; 1.
DR   Gene3D; 3.30.565.10; Histidine kinase-like ATPase, C-terminal domain; 1.
DR   InterPro; IPR036784; AK/P_DHK_N_sf.
DR   InterPro; IPR018955; BCDHK/PDK_N.
DR   InterPro; IPR039028; BCKD/PDK.
DR   InterPro; IPR003594; HATPase_C.
DR   InterPro; IPR036890; HATPase_C_sf.
DR   InterPro; IPR005467; His_kinase_dom.
DR   InterPro; IPR004358; Sig_transdc_His_kin-like_C.
DR   PANTHER; PTHR11947:SF20; [3-METHYL-2-OXOBUTANOATE DEHYDROGENASE [LIPOAMIDE]] KINASE, MITOCHONDRIAL; 1.
DR   PANTHER; PTHR11947; PYRUVATE DEHYDROGENASE KINASE; 1.
DR   Pfam; PF10436; BCDHK_Adom3; 1.
DR   Pfam; PF02518; HATPase_c; 1.
DR   PRINTS; PR00344; BCTRLSENSOR.
DR   SMART; SM00387; HATPase_c; 1.
DR   SUPFAM; SSF69012; alpha-ketoacid dehydrogenase kinase, N-terminal domain; 1.
DR   SUPFAM; SSF55874; ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase; 1.
DR   PROSITE; PS50109; HIS_KIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Direct protein sequencing; Kinase;
KW   Mitochondrion; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Transferase; Transit peptide.
FT   TRANSIT         1..30
FT                   /note="Mitochondrion"
FT                   /evidence="ECO:0000269|PubMed:1377677"
FT   CHAIN           31..412
FT                   /note="Branched-chain alpha-ketoacid dehydrogenase kinase"
FT                   /id="PRO_0000023454"
FT   DOMAIN          159..404
FT                   /note="Histidine kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00107"
FT   BINDING         279
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:11562470,
FT                   ECO:0007744|PDB:1GKZ"
FT   BINDING         279
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000269|PubMed:11562470,
FT                   ECO:0007744|PDB:1GKZ"
FT   BINDING         315
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:11562470,
FT                   ECO:0007744|PDB:1GKZ"
FT   BINDING         328
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000269|PubMed:11562470,
FT                   ECO:0007744|PDB:1GKZ"
FT   BINDING         330
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000269|PubMed:11562470,
FT                   ECO:0007744|PDB:1GKZ"
FT   BINDING         333
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000269|PubMed:11562470,
FT                   ECO:0007744|PDB:1GKZ"
FT   BINDING         334
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:11562470,
FT                   ECO:0007744|PDB:1GKZ"
FT   BINDING         335
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:11562470,
FT                   ECO:0007744|PDB:1GKZ"
FT   BINDING         364
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:11562470,
FT                   ECO:0007744|PDB:1GKZ"
FT   BINDING         367
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:11562470,
FT                   ECO:0007744|PDB:1GKZ"
FT   BINDING         367
FT                   /ligand="K(+)"
FT                   /ligand_id="ChEBI:CHEBI:29103"
FT                   /ligand_note="structural"
FT                   /evidence="ECO:0000269|PubMed:11562470,
FT                   ECO:0007744|PDB:1GKZ"
FT   BINDING         370
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000269|PubMed:11562470,
FT                   ECO:0007744|PDB:1GKZ"
FT   MOD_RES         31
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:7649998,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         192
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O14874"
FT   MOD_RES         233
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:O14874"
FT   MOD_RES         356
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         360
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   CONFLICT        110..124
FT                   /note="RSLPFIIGCNPTILH -> VVFLSSLVATLPYCT (in Ref. 1 and
FT                   2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        222
FT                   /note="C -> S (in Ref. 1 and 2)"
FT                   /evidence="ECO:0000305"
FT   HELIX           57..62
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   STRAND          63..65
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   STRAND          69..71
FT                   /evidence="ECO:0007829|PDB:3TZ4"
FT   HELIX           72..78
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   STRAND          82..84
FT                   /evidence="ECO:0007829|PDB:4E01"
FT   HELIX           85..111
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   HELIX           114..117
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   HELIX           120..138
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   HELIX           145..161
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   TURN            162..164
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   HELIX           165..175
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   HELIX           177..179
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   HELIX           183..209
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   STRAND          221..225
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   HELIX           227..246
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   STRAND          252..257
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   STRAND          262..264
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   HELIX           267..286
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   TURN            287..290
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   STRAND          298..304
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   STRAND          306..315
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   TURN            322..329
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   HELIX           369..379
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   STRAND          383..389
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   TURN            390..392
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   STRAND          393..401
FT                   /evidence="ECO:0007829|PDB:8EGF"
FT   STRAND          403..405
FT                   /evidence="ECO:0007829|PDB:1GKZ"
SQ   SEQUENCE   412 AA;  46474 MW;  D630D3A44728927E CRC64;
     MILTSVLGSG PRSGSSLWPL LGSSLSLRVR STSATDTHHV ELARERSKTV TSFYNQSAID
     VVAEKPSVRL TPTMMLYSGR SQDGSHLLKS GRYLQQELPV RIAHRIKGFR SLPFIIGCNP
     TILHVHELYI RAFQKLTDFP PIKDQADEAQ YCQLVRQLLD DHKDVVTLLA EGLRESRKHI
     EDEKLVRYFL DKTLTSRLGI RMLATHHLAL HEDKPDFVGI ICTRLSPKKI IEKWVDFARR
     LCEHKYGNAP RVRINGHVAA RFPFIPMPLD YILPELLKNA MRATMESHLD TPYNVPDVVI
     TIANNDVDLI IRISDRGGGI AHKDLDRVMD YHFTTAEAST QDPRISPLFG HLDMHSGGQS
     GPMHGFGFGL PTSRAYAEYL GGSLQLQSLQ GIGTDVYLRL RHIDGREESF RI
//
